Recent data from the Global Burden of Disease (GBD) 2023 study reveal a concerning rise in the occupational asbestos exposure burden across Southeast Asia. Although many developed nations have banned asbestos, its use persists in several developing regions. Consequently, the mortality and disability-adjusted life years (DALYs) attributable to this carcinogen increased markedly between 1990 and 2023. This trend underscores a critical public health challenge for regional healthcare providers and policymakers. Furthermore, the findings highlight that the impact of past exposures is now reaching a clinical peak.

Regional Trends and Disease Distribution

The study indicates that age-standardized mortality rates (ASMR) are climbing, with significant disparities based on sex and age. Specifically, males exhibit substantially higher rates of asbestos-related diseases compared to females. This difference likely stems from the male-dominated nature of industries involving mining, construction, and manufacturing. Moreover, the burden remains particularly high among older adults. This demographic pattern reflects the long latency period associated with asbestos-related pathologies. While many countries show an overall increasing trend, the burden in females is also rising continuously in specific sectors. Therefore, clinicians must consider historical occupational history even in retired patients.

Major Causes of Mortality

Tracheal, bronchus, and lung cancer remain the leading causes of death linked to asbestos exposure in Southeast Asia. Mesothelioma follows as the second most prevalent cause. These findings emphasize that the occupational asbestos exposure burden manifests primarily as aggressive thoracic malignancies. Additionally, asbestosis and other chronic respiratory conditions contribute significantly to the overall DALYs. Because these diseases often present at advanced stages, early screening programs for high-risk workers are essential to improve survival rates. Specifically, targeted monitoring of older male workers in construction sectors could facilitate earlier diagnosis.

Mitigating the Occupational Asbestos Exposure Burden

Strengthening control and prevention strategies is now more urgent than ever. Healthcare systems should prioritize the implementation of comprehensive asbestos bans and stricter workplace safety regulations. Additionally, physicians should increase awareness among at-risk populations regarding the symptoms of lung cancer and mesothelioma. By improving diagnostic accuracy and reporting, Southeast Asian countries can better track and eventually reduce this growing health disparity. Finally, international collaboration is necessary to share best practices for managing legacy asbestos in infrastructure.

Frequently Asked Questions

Which cancers are most commonly linked to asbestos exposure?

The most common malignancies include lung cancer (tracheal, bronchus, and lung) and mesothelioma. Other linked conditions include laryngeal and ovarian cancers, although these are less prevalent in the Southeast Asian data compared to thoracic cancers.

Why is the asbestos burden rising in Southeast Asia?

The increase is driven by the continued use of asbestos in industrial sectors and the aging of populations previously exposed. Due to the long latency period of asbestos-related diseases, which can span several decades, exposures from the late 20th century are now manifesting as clinical disease.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Liu XL et al. Temporal trends in mortality and disability from occupational asbestos exposure in Southeast Asia, 1990-2023. J Occup Environ Med. 2026 May 29. doi: 10.1097/JOM.0000000000003768. PMID: 42213479.


2. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2023 (GBD 2023) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME). 2024.


3. World Health Organization. Asbestos: Elimination of Asbestos-Related Diseases. Fact Sheet. 2023.